| NPM1/B23: a multifunctional chaperone in ribosome biogenesis and chromatin remodeling MS Lindström Biochemistry research international 2011 (1), 195209, 2011 | 377 | 2011 |
| Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation K Itahana, H Mao, A Jin, Y Itahana, HV Clegg, MS Lindström, KP Bhat, ... Cancer cell 12 (4), 355-366, 2007 | 298 | 2007 |
| Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis MS Lindström, D Jurada, S Bursac, I Orsolic, J Bartek, S Volarevic Oncogene 37 (18), 2351-2366, 2018 | 227 | 2018 |
| An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction E Macias, A Jin, C Deisenroth, K Bhat, H Mao, MS Lindström, Y Zhang Cancer cell 18 (3), 231-243, 2010 | 225 | 2010 |
| Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer JL Wang, BY Zheng, XD Li, T Ångström, MS Lindström, KL Wallin Clinical Cancer Research 10 (7), 2407-2414, 2004 | 217 | 2004 |
| Emerging functions of ribosomal proteins in gene-specific transcription and translation MS Lindström Biochemical and biophysical research communications 379 (2), 167-170, 2009 | 216 | 2009 |
| PDGF and PDGF receptors in glioma I Nazarenko, SM Hede, X He, A Hedrén, J Thompson, MS Lindström, ... Upsala journal of medical sciences 117 (2), 99-112, 2012 | 212 | 2012 |
| Role of ribosomal protein mutations in tumor development (Review) KM Goudarzi, MS Lindström International Journal of Oncology 48 (4), 1313-1324, 2016 | 194 | 2016 |
| Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53 GL Kelly, S Grabow, SP Glaser, L Fitzsimmons, BJ Aubrey, T Okamoto, ... Genes & development 28 (1), 58-70, 2014 | 182 | 2014 |
| Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation MS Lindstroöm, A Jin, C Deisenroth, GW Wolf, Y Zhang Molecular and cellular biology, 2007 | 173 | 2007 |
| Transcription factor PROX1: its role in development and cancer T Elsir, A Smits, MS Lindström, M Nistér Cancer and metastasis reviews 31, 793-805, 2012 | 169 | 2012 |
| Role of genetic and epigenetic changes in Burkitt lymphoma MS Lindström, KG Wiman Seminars in cancer biology 12 (5), 381-387, 2002 | 154 | 2002 |
| Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation MS Lindström, Y Zhang Journal of Biological Chemistry 283 (23), 15568-15576, 2008 | 148 | 2008 |
| p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53 MS LindstroÈm, U Klangby, KG Wiman Oncogene 20 (17), 2171-2177, 2001 | 137 | 2001 |
| p53-dependent and-independent nucleolar stress responses K Holmberg Olausson, M Nistér, MS Lindström Cells 1 (4), 774-798, 2012 | 117 | 2012 |
| Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation MS Lindström, M Nistér PloS one 5 (3), e9578, 2010 | 102 | 2010 |
| Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts MS Lindström, KG Wiman Oncogene 22 (32), 4993-5005, 2003 | 96 | 2003 |
| MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation MW Jackson, MS Lindström, SJ Berberich Journal of Biological Chemistry 276 (27), 25336-25341, 2001 | 95 | 2001 |
| Immunolocalization of human p14ARF to the granular component of the interphase nucleolus MS Lindström, U Klangby, R Inoue, P Pisa, KG Wiman, CE Asker Experimental Cell Research 256 (2), 400-410, 2000 | 94 | 2000 |
| Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability T Enomoto, MS Lindstrom, A Jin, H Ke, Y Zhang Journal of Biological Chemistry 281 (27), 18463-18472, 2006 | 83 | 2006 |
